Tissue engineering tools for modulation of the immune response.

Tissue engineering scaffolds have emerged as a powerful tool within regenerative medicine. These materials are being designed to create environments that promote regeneration through a combination of: (i) scaffold architecture, (ii) the use of scaffolds as vehicles for transplanting progenitor cells, and/or (iii) localized delivery of inductive factors or genes encoding for these inductive factors. This review describes the techniques associated with each of these components. Additionally, the immune response is increasingly recognized as a factor influencing regeneration. The immune reaction to an implant begins with an acute response to the injury and innate recognition of foreign materials, with the subsequent chronic immune response involving specific recognition of antigens (e.g., transplanted cells) by the adaptive immune response, which can eventually lead to rejection of the implant. Thus, we also describe the impact of each component on the immune response, and strategies (e.g., material design, anti-inflammatory cytokine delivery, and immune cell recruitment/transplantation) to modulate, yet not eliminate, the local immune response in order to promote regeneration, which represents another important tool for regenerative medicine.

[1]  G. Herrero-Beaumont,et al.  Case Number 25: A butterfly rash , 2002, Annals of the rheumatic diseases.

[2]  S. Nakagawa,et al.  Comparison of gene expression efficiency and innate immune response induced by Ad vector and lipoplex. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[3]  Il Keun Kwon,et al.  Proteomic analysis and quantification of cytokines and chemokines from biomaterial surface-adherent macrophages and foreign body giant cells. , 2007, Journal of biomedical materials research. Part A.

[4]  R. Steinman,et al.  Dendritic cells with TGF-β1 differentiate naïve CD4+CD25− T cells into islet-protective Foxp3+ regulatory T cells , 2007, Proceedings of the National Academy of Sciences.

[5]  M. Daha,et al.  IL-10-producing macrophages preferentially clear early apoptotic cells. , 2006, Blood.

[6]  Benjamin G Keselowsky,et al.  Adhesive substrate-modulation of adaptive immune responses. , 2008, Biomaterials.

[7]  David N Sheppard,et al.  CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression , 2008, Nature Biotechnology.

[8]  R. Diegelmann,et al.  Wound healing: an overview of acute, fibrotic and delayed healing. , 2004, Frontiers in bioscience : a journal and virtual library.

[9]  J. Tidball,et al.  Macrophages promote muscle membrane repair and muscle fibre growth and regeneration during modified muscle loading in mice in vivo , 2007, The Journal of physiology.

[10]  James M. Anderson,et al.  Quantitative in vivo cytokine analysis at synthetic biomaterial implant sites. , 2008, Journal of biomedical materials research. Part A.

[11]  S. Lacroix,et al.  Proinflammatory cytokine synthesis in the injured mouse spinal cord: Multiphasic expression pattern and identification of the cell types involved , 2007, The Journal of comparative neurology.

[12]  M. Feldmann,et al.  Different Therapeutic Outcomes in Experimental Allergic Encephalomyelitis Dependant Upon the Mode of Delivery of IL-10: A Comparison of the Effects of Protein, Adenoviral or Retroviral IL-10 Delivery into the Central Nervous System1 , 2001, The Journal of Immunology.

[13]  Strayer Viral gene delivery. , 1999, Expert opinion on investigational drugs.

[14]  S. Oluwole,et al.  Indirect allorecognition in acquired thymic tolerance: induction of donor-specific tolerance to rat cardiac allografts by allopeptide-pulsed host dendritic cells. , 1999, Transplantation.

[15]  M. Mcdaniel,et al.  Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Jessberger,et al.  Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. , 2009, Immunity.

[17]  D. M. Lynn,et al.  Multilayered polyelectrolyte assemblies as platforms for the delivery of DNA and other nucleic acid-based therapeutics. , 2008, Advanced drug delivery reviews.

[18]  J. Wilcox,et al.  Impact of polymer hydrophilicity on biocompatibility: implication for DES polymer design. , 2009, Journal of biomedical materials research. Part A.

[19]  R. Coffman,et al.  Central Nervous System Expression of IL-10 Inhibits Autoimmune Encephalomyelitis1 , 2001, The Journal of Immunology.

[20]  D. Klee,et al.  Topographical control of human macrophages by a regularly microstructured polyvinylidene fluoride surface. , 2008, Biomaterials.

[21]  Jacqueline A. Jones,et al.  Characterization of topographical effects on macrophage behavior in a foreign body response model. , 2010, Biomaterials.

[22]  U. Christians,et al.  Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates , 2006, Nature Medicine.

[23]  G. Prud’homme Gene therapy of autoimmune diseases with vectors encoding regulatory cytokines or inflammatory cytokine inhibitors , 2000, The journal of gene medicine.

[24]  Buddy D. Ratner,et al.  Biomaterial topography alters healing in vivo and monocyte/macrophage activation in vitro. , 2010, Journal of biomedical materials research. Part A.

[25]  Andrés J. García,et al.  Reduced acute inflammatory responses to microgel conformal coatings. , 2008, Biomaterials.

[26]  Steven W. Martin,et al.  Design of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) for chronic inflammatory diseases. , 2003, Advanced drug delivery reviews.

[27]  J. F. Wright,et al.  Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver. , 2007, Blood.

[28]  J. Relton,et al.  α4β1 integrin blockade after spinal cord injury decreases damage and improves neurological function , 2008, Experimental Neurology.

[29]  Lonnie D Shea,et al.  Matrices and scaffolds for DNA delivery in tissue engineering. , 2007, Advanced drug delivery reviews.

[30]  S. Miller,et al.  Permanent protection of PLG scaffold transplanted allogeneic islet grafts in diabetic mice treated with ECDI-fixed donor splenocyte infusions. , 2011, Biomaterials.

[31]  Denis Gris,et al.  Methylprednisolone causes minimal improvement after spinal cord injury in rats, contrasting with benefits of an anti-integrin treatment. , 2005, Journal of neurotrauma.

[32]  B. Davidson,et al.  Poly (lactic-glycolic) acid copolymer encapsulation of recombinant adenovirus reduces immunogenicity in vivo , 1998, Gene Therapy.

[33]  N. Sarvetnick,et al.  Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[34]  D. Mooney,et al.  Hydrogels for tissue engineering: scaffold design variables and applications. , 2003, Biomaterials.

[35]  J. Mao,et al.  Mesenchymal stem cells and tissue engineering. , 2006, Methods in enzymology.

[36]  H. Keirstead,et al.  Reducing inflammation decreases secondary degeneration and functional deficit after spinal cord injury , 2003, Experimental Neurology.

[37]  T. Flotte,et al.  Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[38]  R. Alemany,et al.  Blood clearance rates of adenovirus type 5 in mice. , 2000, The Journal of general virology.

[39]  D. Schaffer,et al.  Engineering biomaterial systems to enhance viral vector gene delivery. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[40]  James M. Anderson,et al.  Foreign body reaction to biomaterials. , 2008, Seminars in immunology.

[41]  Andrew F Adler,et al.  Patterned transgene expression in multiple-channel bridges after spinal cord injury. , 2010, Acta biomaterialia.

[42]  D. Munn,et al.  Creating immune privilege: active local suppression that benefits friends, but protects foes , 2008, Nature Reviews Immunology.

[43]  George P McCabe,et al.  Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component. , 2009, Biomaterials.

[44]  Andrea T. Badillo,et al.  IL-10 overexpression decreases inflammatory mediators and promotes regenerative healing in an adult model of scar formation. , 2008, The Journal of investigative dermatology.

[45]  David H. O'Connor,et al.  Mesenchymal Stem Cells Enhance Allogeneic Islet Engraftment in Nonhuman Primates , 2010, Diabetes.

[46]  G. Comi,et al.  IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis , 2008, Gene Therapy.

[47]  X. Qin,et al.  Plasmacytoid dendritic cells prime IL-10–producing T regulatory cells by inducible costimulator ligand , 2007, The Journal of experimental medicine.

[48]  Stacie A. Chvatal,et al.  Spatial distribution and acute anti-inflammatory effects of Methylprednisolone after sustained local delivery to the contused spinal cord. , 2008, Biomaterials.

[49]  James M. Wilson,et al.  “Stealth” Adenoviruses Blunt Cell-Mediated and Humoral Immune Responses against the Virus and Allow for Significant Gene Expression upon Readministration in the Lung , 2001, Journal of Virology.

[50]  Bo Nilsson,et al.  The role of complement in biomaterial-induced inflammation. , 2007, Molecular immunology.

[51]  Freddie H. Fu,et al.  Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. , 1996, Transplantation.

[52]  J. Babensee,et al.  Biomaterial adjuvant effect is attenuated by anti-inflammatory drug delivery or material selection. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[53]  John G. Graham,et al.  The contribution of plasmid design and release to in vivo gene expression following delivery from cationic polymer modified scaffolds. , 2010, Biomaterials.

[54]  Alberto Mantovani,et al.  Macrophage activation and polarization. , 2008, Frontiers in bioscience : a journal and virtual library.

[55]  D. Mooney,et al.  Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.

[56]  J. Babensee,et al.  Macrophage and dendritic cell phenotypic diversity in the context of biomaterials. , 2011, Journal of biomedical materials research. Part A.

[57]  L. Shea,et al.  Spatially patterned gene expression for guided neurite extension , 2009, Journal of neuroscience research.

[58]  T. Woodruff,et al.  Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment. , 2010, Brain : a journal of neurology.

[59]  James M. Anderson,et al.  Local release of dexamethasone from polymer millirods effectively prevents fibrosis after radiofrequency ablation. , 2006, Journal of biomedical materials research. Part A.

[60]  H. Yoshida,et al.  Effects of inflammatory response on in vivo transgene expression by plasmid DNA in mice. , 2008, Journal of pharmaceutical sciences.

[61]  V. Tuohy,et al.  Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides. , 1990, Journal of immunology.

[62]  R. Marchant,et al.  Biomimetic Fluorocarbon Surfactant Polymers Reduce Platelet Adhesion on PTFE/ePTFE Surfaces , 2009, Journal of biomaterials science. Polymer edition.

[63]  J. Duffield The inflammatory macrophage: a story of Jekyll and Hyde. , 2003, Clinical science.

[64]  K. S. Jones,et al.  Effects of biomaterial-induced inflammation on fibrosis and rejection. , 2008, Seminars in immunology.

[65]  Zhen Gu,et al.  Tailoring nanocarriers for intracellular protein delivery. , 2011, Chemical Society reviews.

[66]  Andrés J. García,et al.  Engineering graded tissue interfaces , 2008, Proceedings of the National Academy of Sciences.

[67]  C. Carlo-Stella,et al.  Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. , 2002, Blood.

[68]  E. Ryan,et al.  Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. , 2000, The New England journal of medicine.

[69]  C. Jobin,et al.  Inhibition of macrophage nuclear factor-kappaB leads to a dominant anti-inflammatory phenotype that attenuates glomerular inflammation in vivo. , 2005, The American journal of pathology.

[70]  Scott D. Putney,et al.  Improving protein therapeutics with sustained-release formulations , 1998, Nature Biotechnology.

[71]  P. Kavehpour,et al.  Incorporation of active DNA/cationic polymer polyplexes into hydrogel scaffolds. , 2010, Biomaterials.

[72]  G. Korbutt,et al.  Comparison of Successful and Unsuccessful Islet/Sertoli Cell Cotransplant Grafts in Streptozotocin-Induced Diabetic Mice , 2007, Cell transplantation.

[73]  Y. Yoon,et al.  Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. , 2005, The Journal of clinical investigation.

[74]  Shaoyi Jiang,et al.  Reduced foreign body reaction to implanted biomaterials by surface treatment with oriented osteopontin , 2008, Journal of biomaterials science. Polymer edition.

[75]  A. Dalmasso,et al.  Reversal of diabetes in non‐immunosuppressed rhesus macaques by intraportal porcine islet xenografts precedes acute cellular rejection , 2004, Xenotransplantation.

[76]  P. Popovich,et al.  Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury , 2008, Experimental Neurology.

[77]  A. Bartholomew,et al.  Mesenchymal Stem Cells in the Induction of Transplantation Tolerance , 2009, Transplantation.

[78]  James M. Anderson,et al.  The topographical effect of electrospun nanofibrous scaffolds on the in vivo and in vitro foreign body reaction. , 2009, Journal of biomedical materials research. Part A.

[79]  Aaron J. Martin,et al.  ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms , 2008, Proceedings of the National Academy of Sciences.

[80]  J. Babensee,et al.  Differential levels of dendritic cell maturation on different biomaterials used in combination products. , 2005, Journal of biomedical materials research. Part A.